{"id":"any-fixed-combination-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is unknown, but it is believed to work by targeting multiple pathways to achieve therapeutic effects.","oneSentence":"This fixed combination therapy works by combining multiple drugs to treat various conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T02:28:37.382Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Various conditions"}]},"trialDetails":[{"nctId":"NCT07496528","phase":"NA","title":"Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-04-01","conditions":"Colorectal Neoplasms, Ileus Postoperative, Postoperative Complication","enrollment":240},{"nctId":"NCT06337032","phase":"PHASE4","title":"A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-27","conditions":"HIV-1-infection","enrollment":350},{"nctId":"NCT02780128","phase":"PHASE1","title":"Next Generation Personalized Neuroblastoma Therapy","status":"TERMINATED","sponsor":"Yael P Mosse","startDate":"2016-07","conditions":"Neuroblastoma, Cancer","enrollment":66},{"nctId":"NCT03075696","phase":"PHASE1, PHASE2","title":"A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2017-02-21","conditions":"Non-Hodgkin's Lymphoma","enrollment":940},{"nctId":"NCT07446725","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Suzhou Genhouse Bio Co., Ltd.","startDate":"2026-02-24","conditions":"Advanced Solid Tumor Cancer","enrollment":152},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT05460520","phase":"NA","title":"DevRobust Treatment for Mal de Débarquement Syndrome","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-01-01","conditions":"Mal de Débarquement Syndrome","enrollment":200},{"nctId":"NCT04746183","phase":"PHASE1, PHASE2","title":"AGILE (Early Phase Platform Trial for COVID-19)","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2020-07-03","conditions":"Covid19","enrollment":600},{"nctId":"NCT07317609","phase":"PHASE1","title":"Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-07-15","conditions":"Esophageal Squamous Cell Carcinoma (ESCC)","enrollment":60},{"nctId":"NCT07315035","phase":"PHASE2","title":"QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2026-01-01","conditions":"Gastric Cancer Stage III","enrollment":74},{"nctId":"NCT03904693","phase":"PHASE3","title":"Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","sponsor":"Actelion","startDate":"2019-07-29","conditions":"Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)","enrollment":187},{"nctId":"NCT07285148","phase":"PHASE1, PHASE2","title":"A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Beijing Pearl Biotechnology Limited Liability Company","startDate":"2026-06","conditions":"Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer","enrollment":253},{"nctId":"NCT07069049","phase":"NA","title":"Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2025-12-28","conditions":"Prostate Cancer","enrollment":190},{"nctId":"NCT07239518","phase":"NA","title":"A Prospective Evaluation of Early Acupuncture for Immediate Continence Enhancement After Prostatectomy","status":"NOT_YET_RECRUITING","sponsor":"Bin Xu","startDate":"2025-12","conditions":"Prostate Cancer, Urinary Incontinence","enrollment":144},{"nctId":"NCT07182461","phase":"NA","title":"The Effects of Dynamic Taping Combined With Corrective Exercises on Cervical Proprioception and Muscle Imbalance in Patients With Upper Crossed Syndrome","status":"RECRUITING","sponsor":"China Medical University Hospital","startDate":"2025-03-13","conditions":"Upper Crossed Syndrome","enrollment":36},{"nctId":"NCT06282315","phase":"PHASE3","title":"Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness","status":"RECRUITING","sponsor":"Insud Pharma","startDate":"2025-09-01","conditions":"Soil-Transmitted Helminths","enrollment":20000},{"nctId":"NCT06865339","phase":"PHASE2","title":"Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Nitin Ohri","startDate":"2025-08-07","conditions":"NSCLC, Locally Advanced","enrollment":76},{"nctId":"NCT03085225","phase":"PHASE1","title":"Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.","status":"COMPLETED","sponsor":"Institut Bergonié","startDate":"2017-05-05","conditions":"Ovarian Carcinoma, Soft Tissue Sarcoma","enrollment":40},{"nctId":"NCT02195479","phase":"PHASE3","title":"A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-12-09","conditions":"Multiple Myeloma","enrollment":706},{"nctId":"NCT06947577","phase":"PHASE4","title":"Pulsed Electromagnetic Field Therapy to a Tailored Exercise Program for Patients Suffering From Chemotherapy-induced Neuropathy Related to Breast Cancer","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-05-01","conditions":"Neuropathic","enrollment":80},{"nctId":"NCT04480242","phase":"","title":"Asthma Research in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Parc de Salut Mar","startDate":"2017-07-26","conditions":"Persistent Asthma, Asthma in Children, Asthma Exacerbation","enrollment":525},{"nctId":"NCT06263231","phase":"PHASE3","title":"A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intensity Therapeutics, Inc.","startDate":"2024-06-28","conditions":"Sarcoma,Soft Tissue","enrollment":333},{"nctId":"NCT05821556","phase":"PHASE2","title":"Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients","status":"RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2023-06-12","conditions":"Adenocarcinoma of the Pancreas","enrollment":240},{"nctId":"NCT04532931","phase":"PHASE2","title":"Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2020-09-03","conditions":"COVID-19","enrollment":192},{"nctId":"NCT05224141","phase":"PHASE3","title":"Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2022-03-24","conditions":"Small Cell Lung Carcinoma","enrollment":460},{"nctId":"NCT07024303","phase":"EARLY_PHASE1","title":"Measurement of Treatment Effects","status":"NOT_YET_RECRUITING","sponsor":"Matthew J O'Brien, PhD, BCBA-D","startDate":"2025-06-15","conditions":"Challenging Behavior, Autism Spectrum Disorder","enrollment":20},{"nctId":"NCT07015307","phase":"NA","title":"Sustainable Exercise and Nutrition Programs for Managing Metabolic Disorders in Older Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alicante","startDate":"2025-06-01","conditions":"Metabolic Syndrome, Aging, Sarcopenia","enrollment":140},{"nctId":"NCT01333046","phase":"PHASE1","title":"Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2012-01","conditions":"Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Disease","enrollment":36},{"nctId":"NCT06971159","phase":"NA","title":"Systemic Vibratory Therapy and Osteopathic Manipulative Treatment in Individuals With Obesity","status":"RECRUITING","sponsor":"Laboratorio de Vibraçoes Mecanicas e Praticas Integrativas","startDate":"2021-03-05","conditions":"Obesity","enrollment":90},{"nctId":"NCT03603184","phase":"PHASE3","title":"Atezolizumab Trial in Endometrial Cancer - AtTEnd","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2018-10-02","conditions":"Endometrial Cancer","enrollment":549},{"nctId":"NCT06104423","phase":"PHASE4","title":"Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients","status":"COMPLETED","sponsor":"Menarini International Operations Luxembourg SA","startDate":"2023-10-02","conditions":"Hypertension","enrollment":266},{"nctId":"NCT06700122","phase":"NA","title":"Clinical Comparative Evaluation of the Use of Photodynamic Therapy in Conjunction With the Use of Vitamin D in Management Stage II Grade B Periodontitis Patients","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-06-01","conditions":"Vitamin D Deficiency","enrollment":24},{"nctId":"NCT06875037","phase":"NA","title":"Patient-related Outcomes When Accelerating Upper Canine Retraction With Fixed Orthodontic Appliances","status":"COMPLETED","sponsor":"Damascus University","startDate":"2023-05-01","conditions":"Class II Division 1 Malocclusion","enrollment":40},{"nctId":"NCT06832475","phase":"NA","title":"Comparing the Impact of Rubber Bands on Teeth Straightening with Clear Aligners Versus Traditional Braces: a Clinical Study","status":"COMPLETED","sponsor":"University of Rome Tor Vergata","startDate":"2023-09-01","conditions":"Class II Malocclusion, IMPA Angle","enrollment":40},{"nctId":"NCT04574583","phase":"PHASE1, PHASE2","title":"Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta \"Trap\"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2020-11-24","conditions":"Metastatic Cancer, Solid Tumors","enrollment":12},{"nctId":"NCT03523572","phase":"PHASE1","title":"Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2018-08-02","conditions":"Breast Cancer, Urothelial Carcinoma","enrollment":86},{"nctId":"NCT06739395","phase":"PHASE2","title":"Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion","status":"RECRUITING","sponsor":"Tianjin Medical University Second Hospital","startDate":"2024-11-01","conditions":"Solid Tumor, Precision Medicine","enrollment":300},{"nctId":"NCT04996004","phase":"PHASE2","title":"A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma","status":"TERMINATED","sponsor":"Pfizer","startDate":"2021-06-22","conditions":"Leiomyosarcoma","enrollment":76},{"nctId":"NCT04675827","phase":"PHASE2","title":"De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade","status":"TERMINATED","sponsor":"Jules Bordet Institute","startDate":"2022-01-17","conditions":"HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer","enrollment":139},{"nctId":"NCT05851326","phase":"NA","title":"Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome","status":"RECRUITING","sponsor":"Sobet AG","startDate":"2023-05-25","conditions":"Myofascial Pain Syndrome - Lower Back, Myofascial Pain Syndrome - Neck, Myofascial Pain Syndrome - Tension Headache","enrollment":126},{"nctId":"NCT05655169","phase":"NA","title":"Which is Better Piezosurgery or Piezosurgery With Laser in Accelerating Orthodontic Tooth Movement","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-10-09","conditions":"Angle Class II","enrollment":63},{"nctId":"NCT06682221","phase":"PHASE3","title":"Effects of Resistance Training and Supplementation in Elderly: Cardiorespiratory and Metabolic Variables","status":"ENROLLING_BY_INVITATION","sponsor":"Federal University of São Paulo","startDate":"2024-02-16","conditions":"Aging, Cardiovascular Health Status, Physical Training","enrollment":120},{"nctId":"NCT03577470","phase":"","title":"An Italian Observation of Antiretroviral Treatment in Participants Taking Darunavir/ Cobicistat Plus Emtricitabine and Tenofovir Alafenamide Fumarate","status":"COMPLETED","sponsor":"Janssen-Cilag S.p.A.","startDate":"2018-06-13","conditions":"Human Immunodeficiency Virus (HIV)","enrollment":246},{"nctId":"NCT04776018","phase":"PHASE1, PHASE2","title":"A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)","status":"TERMINATED","sponsor":"Takeda","startDate":"2021-04-20","conditions":"Relapsed and/or Refractory Multiple Myeloma (RRMM)","enrollment":27},{"nctId":"NCT06620029","phase":"PHASE1, PHASE2","title":"BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"BioMimetix JV, LLC","startDate":"2025-04-01","conditions":"Ovarian Neoplasms, Endometrial Cancer, Endometrial Neoplasm","enrollment":27},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06485154","phase":"PHASE4","title":"Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Witwatersrand, South Africa","startDate":"2024-06-01","conditions":"HIV Prevention","enrollment":100},{"nctId":"NCT06476574","phase":"NA","title":"Retentive Capacity of Bonded Retainer Vs Vacuum-formed and Combined Bonded-vacuum Retainers","status":"RECRUITING","sponsor":"Cairo University","startDate":"2023-09-29","conditions":"Orthodontic Retainer, Fixed Orthodontic Retainer, Orthodontic Relapse","enrollment":45},{"nctId":"NCT02613403","phase":"PHASE2","title":"Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-12-10","conditions":"Hepatitis, Hepatitis C, Digestive System Diseases","enrollment":94},{"nctId":"NCT02291289","phase":"PHASE2","title":"A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2015-04-17","conditions":"Colorectal Cancer","enrollment":1044},{"nctId":"NCT04388904","phase":"PHASE4","title":"Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)","status":"COMPLETED","sponsor":"The Crofoot Research Center, Inc.","startDate":"2021-09-01","conditions":"HIV-1-infection","enrollment":75},{"nctId":"NCT03954132","phase":"","title":"Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-06-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":469},{"nctId":"NCT06318234","phase":"","title":"PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer","status":"RECRUITING","sponsor":"Xiao Chen","startDate":"2024-01-01","conditions":"Rectal Cancer","enrollment":32},{"nctId":"NCT04934514","phase":"PHASE1, PHASE2","title":"Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors","status":"UNKNOWN","sponsor":"SUNHO（China）BioPharmaceutical CO., Ltd.","startDate":"2021-07-06","conditions":"Advanced Solid Tumor","enrollment":97},{"nctId":"NCT05400265","phase":"PHASE1","title":"Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor","status":"COMPLETED","sponsor":"Shanghai Henlius Biotech","startDate":"2022-07-26","conditions":"Adult Solid Tumor","enrollment":9},{"nctId":"NCT06087809","phase":"NA","title":"Improving Short Course Treatment for Common Pediatric Infections","status":"COMPLETED","sponsor":"Boston Children's Hospital","startDate":"2023-02-15","conditions":"Community-acquired Pneumonia, Skin Infection","enrollment":75},{"nctId":"NCT06042777","phase":"NA","title":"Non-pharmacological and TCM-based Treatment for Long COVID Symptoms","status":"UNKNOWN","sponsor":"The Hong Kong Polytechnic University","startDate":"2023-09-30","conditions":"Long Covid19","enrollment":100},{"nctId":"NCT04088604","phase":"PHASE1","title":"Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid Tumors","status":"COMPLETED","sponsor":"Luye Pharma Group Ltd.","startDate":"2019-02-15","conditions":"Advanced Solid Tumor","enrollment":38},{"nctId":"NCT04972773","phase":"NA","title":"Spinal Cord Injury Mental Health Functional Outcomes Improved by Mindfulness","status":"COMPLETED","sponsor":"Queen's University","startDate":"2021-10-04","conditions":"Spinal Cord Injuries, Mindfulness Meditation, Mental Health Wellness 1","enrollment":10},{"nctId":"NCT02834247","phase":"PHASE1","title":"A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors","status":"TERMINATED","sponsor":"Calithera Biosciences, Inc","startDate":"2016-08-12","conditions":"Triple-Negative Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Carcinoma, Squamous Cell","enrollment":41},{"nctId":"NCT05613699","phase":"NA","title":"Exercise for Young Adults With Cancer","status":"COMPLETED","sponsor":"University Hospital Heidelberg","startDate":"2020-09-01","conditions":"Fatigue, Cancer, Physical Activity","enrollment":106},{"nctId":"NCT03798080","phase":"PHASE3","title":"Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-02-19","conditions":"Type 2 Diabetes Mellitus","enrollment":426},{"nctId":"NCT03798054","phase":"PHASE3","title":"Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-02-15","conditions":"Type 2 Diabetes Mellitus","enrollment":878},{"nctId":"NCT04216420","phase":"NA","title":"Electronic Pillbox-enabled SAT Versus DOT for TB Medication Adherence and Treatment Outcomes","status":"COMPLETED","sponsor":"Addis Ababa University","startDate":"2020-06-01","conditions":"Tuberculosis","enrollment":114},{"nctId":"NCT03922477","phase":"PHASE1","title":"A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2019-10-08","conditions":"Acute Myeloid Leukemia","enrollment":13},{"nctId":"NCT03787654","phase":"NA","title":"Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary Incontinence","status":"UNKNOWN","sponsor":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","startDate":"2019-03-01","conditions":"Mixed Urinary Incontinence, Urgency-predominant Mixed Urinary Incontinence","enrollment":282},{"nctId":"NCT05091008","phase":"PHASE2","title":"Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children","status":"COMPLETED","sponsor":"Mansoura University Children Hospital","startDate":"2018-03-01","conditions":"Hepatitis C, Chronic","enrollment":50},{"nctId":"NCT04639076","phase":"NA","title":"Study of a Personalized vs. Standard Approach to Weight Loss Recommendations","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-10-21","conditions":"Overweight and Obesity","enrollment":35},{"nctId":"NCT04190160","phase":"NA","title":"Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)","status":"COMPLETED","sponsor":"Stefano Rizza","startDate":"2018-11-19","conditions":"Type2 Diabetes","enrollment":35},{"nctId":"NCT04871828","phase":"PHASE3","title":"The Efficacy of Leukotriene Inhibitor in Adult Patients With Moderate SARS-COV-2 Symptoms (COVID19)","status":"UNKNOWN","sponsor":"King Abdullah International Medical Research Center","startDate":"2021-02-28","conditions":"Moderate Covid19","enrollment":66},{"nctId":"NCT02627456","phase":"PHASE1","title":"Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-12-09","conditions":"Malaria","enrollment":409},{"nctId":"NCT03114969","phase":"","title":"Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-06-08","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":450},{"nctId":"NCT02185794","phase":"PHASE1","title":"Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2014-06-13","conditions":"Hepatitis C Virus Infection","enrollment":101},{"nctId":"NCT02431975","phase":"PHASE4","title":"Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial","status":"COMPLETED","sponsor":"Columbia University","startDate":"2015-08","conditions":"HIV","enrollment":73},{"nctId":"NCT04492501","phase":"NA","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"Covid19, Cytokine Release Syndrome, Critical Illness","enrollment":600},{"nctId":"NCT02616029","phase":"PHASE3","title":"Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2015-12-17","conditions":"HIV-1 Infection","enrollment":66},{"nctId":"NCT02073123","phase":"PHASE1, PHASE2","title":"Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma","status":"COMPLETED","sponsor":"NewLink Genetics Corporation","startDate":"2014-07","conditions":"Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma","enrollment":132},{"nctId":"NCT04121910","phase":"PHASE1","title":"A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2019-11-07","conditions":"Solid Tumour","enrollment":16},{"nctId":"NCT01741038","phase":"PHASE2, PHASE3","title":"AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer","status":"WITHDRAWN","sponsor":"Mirror Biologics, Inc.","startDate":"2017-12","conditions":"Metastatic Colorectal Cancer","enrollment":""},{"nctId":"NCT03213067","phase":"","title":"Mitochondrial and Microbiota Relationship","status":"COMPLETED","sponsor":"Newcastle University","startDate":"2017-04-11","conditions":"Mitochondrial Diseases","enrollment":40},{"nctId":"NCT03959865","phase":"","title":"GLP-1 REceptor Agonists and Real World EvIdeNce","status":"UNKNOWN","sponsor":"University of Padova","startDate":"2018-12-19","conditions":"Type 2 Diabetes","enrollment":6000},{"nctId":"NCT03902340","phase":"NA","title":"Comparison of the Efficacy, Tolerability and Safety of actiTENS to Those of Level 2 Analgesic Treatments.","status":"UNKNOWN","sponsor":"Sublimed","startDate":"2018-12-19","conditions":"Knee Osteoarthritis","enrollment":110},{"nctId":"NCT01964391","phase":"PHASE3","title":"A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2014-02-21","conditions":"Breast Cancer","enrollment":174},{"nctId":"NCT01985334","phase":"PHASE4","title":"Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-02-14","conditions":"COPD","enrollment":4389},{"nctId":"NCT01641367","phase":"PHASE4","title":"A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2013-02-22","conditions":"HIV-1 Infection","enrollment":545},{"nctId":"NCT03535558","phase":"","title":"Fluoroquinolone Associated Disability","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-05-17","conditions":"Bronchitis, Sinusitis, Urinary Tract Infections","enrollment":239306},{"nctId":"NCT03773536","phase":"PHASE4","title":"Efficacy and Safety of Artesunate + Amodiaquine With SLD of Primaquine for Treatment of Falciparum Malaria in Zanzibar","status":"COMPLETED","sponsor":"Professor Anders Björkman","startDate":"2017-05-09","conditions":"Plasmodium Falciparum Malaria","enrollment":146},{"nctId":"NCT02046603","phase":"PHASE3","title":"A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2014-03-04","conditions":"Rheumatoid Arthritis","enrollment":162},{"nctId":"NCT03578042","phase":"PHASE4","title":"Fixed-Free HTN Trial","status":"UNKNOWN","sponsor":"Hotel Dieu de France Hospital","startDate":"2017-04-01","conditions":"Hypertension","enrollment":100},{"nctId":"NCT03405454","phase":"PHASE2","title":"A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2017-10-09","conditions":"Ovarian Clear Cell Carcinoma","enrollment":46},{"nctId":"NCT03518463","phase":"NA","title":"Enhanced Recovery After Surgery for Emergency Caesarean Deliveries","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2017-06-20","conditions":"Pregnancy Related","enrollment":160},{"nctId":"NCT02427399","phase":"NA","title":"Conducting Outreach to Improve Cervical Cancer Screening Rates Among Underscreened Patients","status":"COMPLETED","sponsor":"Fenway Community Health","startDate":"2013-01","conditions":"Uterine Cervical Neoplasms","enrollment":1100},{"nctId":"NCT03179735","phase":"PHASE4","title":"Mouthwashes During Orthodontic Treatment","status":"UNKNOWN","sponsor":"University of Taubate","startDate":"2017-06-01","conditions":"Gingivitis","enrollment":60},{"nctId":"NCT02723981","phase":"PHASE4","title":"COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials","status":"WITHDRAWN","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2016-04","conditions":"Stable Angina, Unstable Angina, STEMI","enrollment":""},{"nctId":"NCT01165307","phase":"PHASE4","title":"Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia","status":"COMPLETED","sponsor":"Abimbola Famuyide","startDate":"2009-08","conditions":"Menorrhagia","enrollment":77},{"nctId":"NCT02126436","phase":"NA","title":"Acupuncture for the Treatment of Phantom Limb Syndrome","status":"COMPLETED","sponsor":"London South Bank University","startDate":"2014-10","conditions":"Phantom Limb Syndrome","enrollment":15},{"nctId":"NCT01126242","phase":"PHASE4","title":"Tape Versus Semirigid Versus Lace-up Ankle Support in the Treatment of Acute Lateral Ankle Ligament Injury.","status":"COMPLETED","sponsor":"Gelre Hospitals","startDate":"2010-05","conditions":"Grade II and III Acute Lateral Ankle Ligament Injuries","enrollment":182},{"nctId":"NCT02220218","phase":"PHASE1","title":"Bioequivalence Study of Metformin Component of Canagliflozin and Metformin Fixed Dose Combination Immediate Release (IR) Tablet Comparing With Metformin IR Tablet Co-administered With Canagliflozin Tablet in Healthy Fed and Fasted Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-08","conditions":"Healthy","enrollment":2},{"nctId":"NCT00567164","phase":"PHASE3","title":"Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-10","conditions":"Contraception, Ovulation Inhibition, Contraceptives, Oral","enrollment":1887},{"nctId":"NCT01637246","phase":"","title":"A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-04","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":4385}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":115,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Any Fixed Combination Therapy","genericName":"Any Fixed Combination Therapy","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Any Fixed Combination Therapy, also known as ACORVIO, is a small molecule inhibitor that targets Lanosterol 14-alpha demethylase, specifically inhibiting the cytochrome P450 51 enzyme. It has been studied in various clinical trials for conditions such as HIV-1-infection, Advanced Solid Tumor, Colorectal Cancer, Type 2 Diabetes Mellitus, and Grade II and III Acute Lateral Ankle Ligament Injuries.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}